| 51. |
|
|
| 52. |
- Abdul-Sattar Aljabery, Firas, et al.
(författare)
-
Treatment and prognosis of patients with urinary bladder cancer with other primary cancers: a nationwide population-based study in the Bladder Cancer Data Base Sweden (BladderBaSe)
- 2020
-
Ingår i: BJU International. - : Wiley. - 1464-4096 .- 1464-410X. ; 126:5, s. 625-632
-
Tidskriftsartikel (refereegranskat)abstract
- Objective To study how patients with urinary bladder cancer (UBC) with previous or concomitant other primary cancers (OPCs) were treated, and to investigate their prognosis. Patients And Methods Using nationwide population-based data in the Bladder Cancer Data Base Sweden (BladderBaSe), we analysed the probability of treatment with curative intent, and UBC-specific and overall survival (OS) in patients with UBC diagnosed in the period 1997-2014 with or without OPC. The analyses considered the patient's characteristics, UBC tumour stage at diagnosis, and site of OPC. Results There were 38 689 patients, of which 9804 (25%) had OPCs. Those with synchronous OPCs more often had T2 and T3 tumours and clinically distant disease at diagnosis than those with UBC only. Patients with synchronous prostate cancer, female genital cancer and lower gastro-intestinal cancer were more often treated with curative intent than patients with UBC only. When models of survival were adjusted for age at diagnosis, marital status, education, year of diagnosis, Charlson Comorbidity Index and T-stage, UBC-specific survival was similar to patients with UBC only, but OS was lower for patients with synchronous OPC, explained mainly by deaths in OPC primaries with a bad prognosis. Conclusions OPC is common in patients with UBC. Treatment for UBC, after or in conjunction with an OPC, should not be neglected and carries just as high a probability of success as treatment in patients with UBC only. The needs of patients with UBC and OPC, and optimisation of their treatment considering their complicated disease trajectory are important areas of research.
|
|
| 53. |
- Abdulkadir, M, et al.
(författare)
-
Polygenic Score for Body Mass Index Is Associated with Disordered Eating in a General Population Cohort
- 2020
-
Ingår i: Journal of clinical medicine. - : MDPI AG. - 2077-0383. ; 9:4
-
Tidskriftsartikel (refereegranskat)abstract
- Background: Disordered eating (DE) is common and is associated with body mass index (BMI). We investigated whether genetic variants for BMI were associated with DE. Methods: BMI polygenic scores (PGS) were calculated for participants of the Avon Longitudinal Study of Parents and Children (ALSPAC; N = 8654) and their association with DE tested. Data on DE behaviors (e.g., binge eating and compensatory behaviors) were collected at ages 14, 16, 18 years, and DE cognitions (e.g., body dissatisfaction) at 14 years. Mediation analyses determined whether BMI mediated the association between the BMI-PGS and DE. Results: The BMI-PGS was positively associated with fasting (OR = 1.42, 95% CI = 1.25, 1.61), binge eating (OR = 1.28, 95% CI = 1.12, 1.46), purging (OR = 1.20, 95% CI = 1.02, 1.42), body dissatisfaction (Beta = 0.99, 95% CI = 0.77, 1.22), restrained eating (Beta = 0.14, 95% CI = 0.10, 1.17), emotional eating (Beta = 0.21, 95% CI = 0.052, 0.38), and negatively associated with thin ideal internalization (Beta = −0.15, 95% CI = −0.23, −0.07) and external eating (Beta = −0.19, 95% CI = −0.30, −0.09). These associations were mainly mediated by BMI. Conclusions: Genetic variants associated with BMI are also associated with DE. This association was mediated through BMI suggesting that weight potentially sits on the pathway from genetic liability to DE.
|
|
| 54. |
- Abdulkarim, Zakaryah
(författare)
-
Limb ownership and voluntary action : human behavioral and neuroimaging studies
- 2020
-
Doktorsavhandling (övrigt vetenskapligt/konstnärligt)abstract
- To be able to interact with our surroundings in a goal directed manner, we need to have sense what our body is made up of as well as a sense of being able to control our body. These two experiences, the sense of body ownership and the sense of agency, respectively, are fundamental to our self-perception but have historically not received any notable attention from the scientific community. This lack of interest probably stems from the fact that these experiences are phenomenologically thin in our everyday lives and that we cannot voluntarily turn them off, they are constantly there. However, for patients suffering from disturbances in the processes underlying these experiences, their importance becomes exceedingly clear. Lesions in the frontal, temporal or parietal lobe can lead to patients losing the sense of ownership of their limb (asomatognosia), and sometimes even attributing the limb to someone else (somatoparaphrenia). Similarly, patients suffering from lesions in the frontal lobe, parietal lobe or corpus callosum can experience a lack of control over their own hand (anarchic hand syndrome), while patients suffering from schizophrenia display difficulties in distinguishing self-generated from externally generated actions, implicating disturbances in the processes underlying the sense of agency. With the discovery of body illusions, combined with functional neuroimaging, it became possible to study the perceptual and neural mechanisms of the sense of body ownership in healthy volunteers. Studies using these illusions have elucidated the perceptual rules of body ownership as well as its neural correlates and has given rise to a number of different philosophical, neurocognitive and computational models of the sense of body ownership. Meanwhile, the sense of agency has mostly been studied disconnected from the sense of body ownership, focusing on agency over self-generated external sensory effects such as auditory tones. This thesis sought to bring these two experiences together and advance our knowledge of the perceptual and neural mechanisms underlying the sense of body ownership and the sense of agency as well how these two experiences interact. Studies I & II investigate certain aspects of the sense of body ownership, and in particular its relation to the visuo-proprioceptive recalibration of limb position often seen in bodily illusions. Study III investigated how this visuo-proprioceptive recalibration is related to voluntary, but unconscious movements. Study IV investigated the neural correlates of the sense of body ownership and agency as well as their interaction. In Study I, we present empirical evidence in favor of models where the subjective sense of limb ownership is not reliant on a visuo-proprioceptive recalibration of perceived limb position. In Study II, we show that the subjective sense of limb ownership and the visuo-proprioceptive recalibration of limb position have similar temporal decay curves, suggestive of a causal relationship between them. In Study III, we show that the increase in the recalibration of limb position seen in active movements is not dependent on conscious intention, action awareness or salient error signals, indicative of an unconscious efference copy-based mechanism. Finally, in Study IV, we identify brain regions in the frontal and parietal lobe which are associated with the sense of body ownership, while brain regions in the frontal and temporal lobe are associated with the sense of agency. We show that the sense of agency in the presence of a sense of body ownership (i.e., agency of bodily actions) is associated with increased activity in the primary sensory cortex, whereas the sense of agency in the absence of ownership (i.e., agency of external events) is associated with increased activity in the visual association cortex. Together, these findings shed light on the perceptual and neural mechanisms underlying the sense of body ownership and agency as well as their interaction.
|
|
| 55. |
- Abdulkarim, Z, et al.
(författare)
-
Sustained rubber hand illusion after the end of visuotactile stimulation with a similar time course for the reduction of subjective ownership and proprioceptive drift
- 2021
-
Ingår i: Experimental brain research. - : Springer Science and Business Media LLC. - 1432-1106 .- 0014-4819. ; 239:12, s. 3471-3486
-
Tidskriftsartikel (refereegranskat)abstract
- The rubber hand illusion is a perceptual illusion in which participants experience an inanimate rubber hand as their own when they observe this model hand being stroked in synchrony with strokes applied to the person’s real hand, which is hidden. Earlier studies have focused on the factors that determine the elicitation of this illusion, the relative contribution of vision, touch and other sensory modalities involved and the best ways to quantify this perceptual phenomenon. Questionnaires serve to assess the subjective feeling of ownership, whereas proprioceptive drift is a measure of the recalibration of hand position sense towards the rubber hand when the illusion is induced. Proprioceptive drift has been widely used and thought of as an objective measure of the illusion, although the relationship between this measure and the subjective illusion is not fully understood. Here, we examined how long the illusion is maintained after the synchronous visuotactile stimulation stops with the specific aim of clarifying the temporal relationship in the reduction of both subjective ownership and proprioceptive drift. Our results show that both the feeling of ownership and proprioceptive drift are sustained for tens of seconds after visuotactile stroking has ceased. Furthermore, our results indicate that the reduction of proprioceptive drift and the feeling of ownership follow similar time courses in their reduction, suggesting that the two phenomena are temporally correlated. Collectively, these findings help us better understand the relationships of multisensory stimulation, subjective ownership, and proprioceptive drift in the rubber hand illusion.
|
|
| 56. |
- Abdulla, Maysaa, et al.
(författare)
-
Cell-of-origin determined by both gene expression profiling and immunohistochemistry is the strongest predictor of survival in patients with diffuse large B-cell lymphoma
- 2020
-
Ingår i: American Journal of Hematology. - : Wiley. - 0361-8609 .- 1096-8652. ; 95:1, s. 57-67
-
Tidskriftsartikel (refereegranskat)abstract
- The tumor cells in diffuse large B-cell lymphomas (DLBCL) are considered to originate from germinal center derived B-cells (GCB) or activated B-cells (ABC). Gene expression profiling (GEP) is preferably used to determine the cell of origin (COO). However, GEP is not widely applied in clinical practice and consequently, several algorithms based on immunohistochemistry (IHC) have been developed. Our aim was to evaluate the concordance of COO assignment between the Lymph2Cx GEP assay and the IHC-based Hans algorithm, to decide which model is the best survival predictor. Both GEP and IHC were performed in 359 homogenously treated Swedish and Danish DLBCL patients, in a retrospective multicenter cohort. The overall concordance between GEP and IHC algorithm was 72%; GEP classified 85% of cases assigned as GCB by IHC, as GCB, while 58% classified as non-GCB by IHC, were categorized as ABC by GEP. There were significant survival differences (overall survival and progression-free survival) if cases were classified by GEP, whereas if cases were categorized by IHC only progression-free survival differed significantly. Importantly, patients assigned as non-GCB/ABC both by IHC and GEP had the worst prognosis, which was also significant in multivariate analyses. Double expression of MYC and BCL2 was more common in ABC cases and was associated with a dismal outcome. In conclusion, to determine COO both by IHC and GEP is the strongest outcome predictor to identify DLBCL patients with the worst outcome.
|
|
| 57. |
- Abdulla, Maysaa, et al.
(författare)
-
PD-L1 and IDO1 are potential targets for treatment in patients with primary diffuse large B-cell lymphoma of the CNS
- 2021
-
Ingår i: Acta Oncologica. - : Taylor & Francis. - 0284-186X .- 1651-226X. ; 60:4, s. 531-538
-
Tidskriftsartikel (refereegranskat)abstract
- BackgroundProgrammed cell death 1 (PD-1) and its ligands PD-L1 and PD-L2, as well as Indoleamine 2,3-deoxygenase (IDO1) can be expressed both by tumor and microenvironmental cells and are crucial for tumor immune escape. We aimed to evaluate the role of PD-1, its ligands and IDO1 in a cohort of patients with primary diffuse large B-cell lymphoma of the CNS (PCNSL).Material and methodsTissue microarrays (TMAs) were constructed in 45 PCNSL cases. RNA extraction from whole tissue sections and RNA sequencing were successfully performed in 33 cases. Immunohistochemical stainings for PD-1, PD-L1/paired box protein 5 (PAX-5), PD-L2/PAX-5 and IDO1, and Epstein-Barr virus encoding RNA (EBER) in situ hybridization were analyzed.ResultsHigh proportions of PD-L1 and PD-L2 positive tumor cells were observed in 11% and 9% of cases, respectively. High proportions of PD-L1 and PD-L2 positive leukocytes were observed in 55% and 51% of cases, respectively. RNA sequencing revealed that gene expression of IDO1 was high in patients with high proportion of PD-L1 positive leukocytes (p = .01). Protein expression of IDO1 in leukocytes was detected in 14/45 cases, in 79% of these cases a high proportion of PD-L1 positive leukocytes was observed. Gene expression of IDO1 was high in EBER-positive cases (p = .0009) and protein expression of IDO1 was detected in five of six EBER-positive cases.ConclusionOur study shows a significant association between gene and protein expression of IDO1 and protein expression of PD-L1 in the tumor microenvironment of PCNSL, possibly of importance for prediction of response to immunotherapies.
|
|
| 58. |
- Abdullah, Laila, et al.
(författare)
-
The Influence of Baseline Alzheimer's Disease Severity on Cognitive Decline and CSF Biomarkers in the NILVAD Trial.
- 2020
-
Ingår i: Frontiers in neurology. - : Frontiers Media SA. - 1664-2295. ; 11
-
Tidskriftsartikel (refereegranskat)abstract
- We examined the effects of a dihydropyridine calcium channel blocker nilvadipine with anti-inflammatory properties on cognition and cerebrospinal fluid (CSF) biomarkers by baseline Alzheimer's disease (AD) severity. Exploratory analyses were performed on the dataset (n = 497) of a phase III randomized placebo-controlled trial to examine the response to nilvadipine in AD subjects stratified by baseline AD severity into very mild (MMSE ≥ 25), mild (MMSE 20-24) and moderate AD (MMSE < 20). The outcome measures included total and subscale scores of the Alzheimer's Disease Assessment Scale Cognitive 12 (ADAS-Cog 12), the Clinical Dementia Rating Scale sum of boxes (CDR-sb) and the AD composite score (ADCOMS). Cerebrospinal fluid biomarkers Aβ38, Aβ40, Aβ42, neurofilament light chain (NFL), neurogranin, YKL-40, total tau and P181 tau (ptau) were measured in a subset of samples (n = 55). Regression analyses were adjusted for confounders to specifically examine the influence of nilvadipine and baseline AD severity on cognitive outcomes over 78-weeks. Compared to their respective placebo-controls, nilvadipine-treated, very mild AD subjects showed less decline, whereas moderate AD subjects showed a greater cognitive decline on the ADAS-Cog 12 test and the ADCOMS. A lower decline was observed after nilvadipine treatment for a composite memory trait in very mild AD subjects and a composite language trait in mild AD subjects. Cerebrospinal fluid Aβ42/Aβ40 ratios were increased in mild AD and decreased in moderate AD patients treated with nilvadipine, compared to their respective controls. Among moderate AD subjects, levels of ptau, total tau, neurogranin and YKL-40 increased in subjects treated with nilvadipine compared to placebo. These studies suggest that baseline AD severity influenced the treatment outcome in the NILVAD trial and that future clinical trials of nilvadipine should be restricted to mild and very mild AD patients. Trial Registration: NCT02017340 Registered 20 December 2013, https://clinicaltrials.gov/ct2/show/NCT02017340 EUDRACT Reference Number 2012-002764-27 Registered 04 February 2013, https://www.clinicaltrialsregister.eu/ctr-search/search?query=2012-002764-27.
|
|
| 59. |
- Abdullahi, Mohamed Farah, et al.
(författare)
-
Factors contributing to the uptake of childhood vaccination in Galkayo District, Puntland, Somalia
- 2020
-
Ingår i: Global Health Action. - : Taylor & Francis. - 1654-9716 .- 1654-9880. ; 13:1
-
Tidskriftsartikel (refereegranskat)abstract
- BACKGROUND: As in many Sub-Saharan African countries, the health system in Somalia is not operating at the capacity needed to lift childhood vaccination coverage to ninety percent or above, as recommended by United Nations Children's Fund. Current national estimates of coverage for the six major vaccine preventable childhood diseases range from thirty to sixty percent. Infectious disease outbreaks continue to pose significant challenges for the country's health authorities.OBJECTIVE: This important qualitative study, conducted in Galkayo District, Somalia, investigates limiting factors associated with childhood vaccination uptake from the perspective of both communities and health care workers.METHODS: Qualitative information was collected through six focus group discussions with parents (n = 48) and five one-to-one interviews with health workers (n = 15) between March and May 2017, in three settings in the Galkayo District - Galkayo city, Bayra and Bacadwayn.RESULTS: From a health system perspective, the factors are: awareness raising, hard to reach areas, negative attitudes and perceived knowledge of health workers, inadequate supplies and infrastructure, and missed vaccination opportunities. From the perspective of individuals and communities the factors are: low trust in vaccines, misinterpretation of religious beliefs, vaccine refusals, Somalia's patriarchal system and rumours and misinformation. Parents mostly received immunization information from social mobilizers and health facilities. Fathers, who are typically family decision-makers, were poorly informed. The findings highlight the need for in-service training to enable health workers to improve communication with parents, particularly fathers, peripheral communities and local religious leaders.CONCLUSIONS: Enhancing knowledge and awareness of vaccination among parents is crucial. Fathers' involvement is lacking. This may be boosted by highlighting fathers' obligation to protect their children's health through vaccination. It is also important that men engage with the wider community in decision-making and advance towards the global vaccination targets.
|
|
| 60. |
- Abdulreda, MH, et al.
(författare)
-
Challenges in stem cell-derived islet replacement therapy can be overcome
- 2021
-
Ingår i: Cell transplantation. - : SAGE Publications. - 1555-3892 .- 0963-6897. ; 30, s. 9636897211045320-
-
Tidskriftsartikel (refereegranskat)abstract
- In this Commentary, we echo the conclusions of a recent review titled “ The promise of stem cell-derived islet replacement therapy,” which highlighted recent advances in producing glucose responsive “islets” from stem cells and the benefits of their use in islet transplant therapy in type 1 diabetes (T1D). The review also outlined the status of clinical islet transplantation and the challenges that have prevented it from reaching its full therapeutic promise. We agree with the conclusions of the review and suggest that the identified challenges may be overcome by using the eye anterior chamber as an islet transplant site. We anticipate that the combination of stem cell-derived islets and intraocular transplant could help this promising T1D therapy reach full fruition.
|
|
